Results 211 to 220 of about 846,419 (356)
Vesico-Intestinal Fistula: Report of a Case: End Results
F. F. Doggett
openalex +2 more sources
This prospective study investigated the feasibility of stabilised hyaluronic acid gel as a rectal spacer in gynaecological cancer brachytherapy. In twelve patients, the spacer was successfully inserted into the rectovaginal space without serious adverse events, had high visibility on MRI, increased the target‐to‐rectum distance compared with no spacer ...
Carminia Lapuz +8 more
wiley +1 more source
INTESTINAL FISTULAS IN CROHNS DISEASE: A COMPLEX CHALLENGE - A MOROCCAN EXPERIENCE
K. Attaqi +6 more
openalex +1 more source
Renal screening sonography—A comparative study in a Portuguese basic emergency service
Renal sonography screening aids in clinical decision‐making for patients with suspected renal colic. This study intends to compare the accuracy and pertinence of sonographic findings obtained by a sonographer in a Basic Emergency Service (BES) with that of radiologists at Referral Hospital (RH) in Portugal. Renal sonography screening was able to detect
Sérgio Miravent +9 more
wiley +1 more source
OBSERVATIONS ON DIGESTION IN THE PIG USING A RE-ENTRANT INTESTINAL FISTULA
H. M. Cunningham +2 more
semanticscholar +1 more source
Feeding difficulties in children with esophageal atresia: A parent‐reported multicenter study
Abstract Objective Feeding difficulties (FDs) are common among children with esophageal atresia (EA) and tracheoesophageal fistula (TEF), but knowledge about their prevalence and risk factors is limited. This multicenter study aimed to assess the prevalence, subtypes, and associated factors of FD in children with EA/TEF. Methods Parents of children who
Tut Galai +7 more
wiley +1 more source
Liver transplantation: From the laboratory to the clinic and beyond [PDF]
Marino, IR, Starzl, TE
core
Real‐world data on STRIDE‐II treatment targets in a pediatric cohort with inflammatory bowel disease
Abstract Objectives STRIDE (selecting therapeutic targets in inflammatory bowel disease) established evidence‐based targets for treat‐to‐target strategies in IBD. STRIDE‐II designates clinical remission, C‐reactive protein (CRP) normalization, and fecal calprotectin (FC) reduction as short‐ to intermediate‐term targets, and mucosal healing as a long ...
Marie‐Luise Frank +9 more
wiley +1 more source

